BSN repricing to draw on US heat
EQT-owned German bandage maker BSN Medical (B/B2) is looking to reprice its €740m term loan ‘B’ at tighter terms just three months after signing, with leveraged finance bankers confident that the strength of the US loan market would make the adjustment possible.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
